Clinical trial
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to…
NCT00395018 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00395018 |
|---|---|
| Title | Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection |
| Official title | Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | entecavir |
| Enrollment | 109 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Nov 2, 2006 |
| Last update posted | May 31, 2012 |
| Countries | Argentina, Australia, Brazil, France, Italy, South Korea, Spain, Taiwan, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: